A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-190)(COMPLETED)

Merck Sharp & Dohme (MSD)

Status and phase: Completed; Phase 3

Conditions: Postoperative Pain

Treatments: Drug: Comparator: valdecoxib, placebo; Drug: MK0966, rofecoxib

Study type: Interventional

Funder types: Industry

Identifiers

NCT00092339

2004_069

0966-190

Details and patient eligibility

About

The purpose of this study is to compare the safety and effectiveness of two approved drugs in the treatment of pain following dental surgery.

Full description

The duration of treatment is 1 day.

Enrollment: 125 estimated patients

Sex: All

Ages: 16+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Impaction of a molar tooth requiring removal

Exclusion criteria

• Any known allergy to the study drugs

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind